Psychedelic drug stocks are a very progressive investing option for investors seeking high-growth opportunities. So why aren't more Millennials jumping on the bandwagon?
Psychedelic drug stocks are a very progressive investing option for investors seeking high-growth opportunities. So why aren't more Millennials jumping on the bandwagon?
Wesana Health commences trading on the CSE, symbol "WESA".
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Field Trip is now eligible for clearing and settlement through the DTC, boosting liquidity in the stock.
Red Light Holland granted patent pending status for its 'Find Your Dose' microdosing kit.
UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".
Mydecine announces a new partnership with LeadGen Labs, aimed at improving its drug synthesis operations.
MindMed commences "Project Angie": psychedelic drug R&D aimed at treating pain, involving psychedelics including LSD.
Psychedelic stocks have become extremely concentrated -- like other sectors. Here's why we see that changing in this sector.
Optimi Health announces its product development agreement with Numinus Wellness is advancing toward a human trial.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now